Global Molecular Scissors Technology Market Growth (Status and Outlook) 2024-2030

Global Molecular Scissors Technology Market Growth (Status and Outlook) 2024-2030

Molecular scissors technology is a tool for cutting long chains of DNA molecules. Its essence is a restriction enzyme. They can find a specific "cutting point" on DNA, and cut the double strands of DNA molecules staggered after recognition.

The global Molecular Scissors Technology market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Molecular Scissors Technology Industry Forecast” looks at past sales and reviews total world Molecular Scissors Technology sales in 2022, providing a comprehensive analysis by region and market sector of projected Molecular Scissors Technology sales for 2023 through 2029. With Molecular Scissors Technology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Scissors Technology industry.

This Insight Report provides a comprehensive analysis of the global Molecular Scissors Technology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Molecular Scissors Technology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Molecular Scissors Technology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Scissors Technology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Scissors Technology.

In 1968, Dr. Werner Albert, Dr. Daniel Nathans, and Dr. Hamilton Smith first extracted restriction enzymes from E. coli. They were able to find specific "cut points" on DNA , And cut the double-stranded DNA molecules in a staggered manner. People call this restriction enzyme "molecular scissors". This "molecular scissors" can cut off individual genes completely. Since the 1970s, more than 400 "molecular scissors" have been isolated and extracted, and many of these "molecular scissors" have been identified. With all kinds of "molecular scissors", people can cut long chains of DNA molecules at will. Due to the discovery of restriction enzymes, Albert, Smith and Nathans shared the 1978 Nobel Prize in Physiology and Medicine.

This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Scissors Technology market by product type, application, key players and key regions and countries.

Segmentation by Type:
Cas9
TALENs and MegaTALs
ZFN
Others

Segmentation by Application:
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Cas9
TALENs and MegaTALs
ZFN
Others

Segmentation by Application:
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cibus
Thermo Fisher Scientific, Inc.
Merck
Recombinetics
Sangamo Therapeutics
Editas Medicine
Precision BioSciences
Intellia Therapeutics, Inc.
Caribou Biosciences, Inc
Cellectis

Please note: The report will take approximately 2 business days to prepare and deliver.